Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Preziosa, Paolo (6506754661)"

Filter results by typing the first few letters
Now showing 1 - 11 of 11
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Brain reserve against physical disability progression over 5 years in multiple sclerosis
    (2016)
    Sumowski, James F. (16029364600)
    ;
    Rocca, Maria A. (34973365100)
    ;
    Leavitt, Victoria M. (16230419900)
    ;
    Meani, Alessandro (37018650000)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Preziosa, Paolo (6506754661)
    ;
    Habeck, Christian G. (6603426570)
    ;
    Filippi, Massimo (7202268530)
    Objective: The brain reserve hypothesis links larger maximal lifetime brain growth (MLBG, estimated with intracranial volume [ICV]) with lower risk for cognitive decline/dementia. We examined whether larger MLBG is also linked to less physical disability progression over 5 years in a prospective sample of treatment-naive patients with multiple sclerosis (MS). Methods: Physical disability was measured with the Expanded Disability Status Scale (EDSS) at baseline and 5-year follow-up in 52 treatment-naive Serbian patients with MS. MRI measured disease burden (cerebral atrophy, T2 lesion volume) and MLBG: a genetically determined, premorbid (established during adolescence, stable thereafter) patient characteristic estimated with ICV (adjusted for sex). Logistic regression tested whether MLBG (smaller vs larger) predicts disability progression (stable vs worsened) independently of disease burden. Results: Disability progression was observed in 29 (55.8%) patients. Larger MLBG predicted lower risk for progression (odds ratio 0.13, 95% confidence interval 0.02-0.78), independently of disease burden. We also calculated absolute change in EDSS scores, and observed that patients with smaller MLBG showed worse EDSS change (0.91 ± 0.71) than patients with larger MLBG (0.42 ± 0.87). Conclusions: Larger MLBG was linked to lower risk for disability progression in patients with MS over 5 years, which is the first extension of the brain reserve hypothesis to physical disability. MLBG (ICV) represents a clinically available metric that may help gauge risk for future disability in patients with MS, which may advance the science and practice of early intervention. Potential avenues for future research are discussed. © 2016 American Academy of Neurology.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Clinically isolated syndrome suggestive of multiple sclerosis: Dynamic patterns of gray and white matter changes - A 2-year MR imaging study
    (2016)
    Rocca, Maria A. (34973365100)
    ;
    Preziosa, Paolo (6506754661)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Dackovic, Jelena (19034069600)
    ;
    Stosic-Opincal, Tatjana (55886486600)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Filippi, Massimo (7202268530)
    Purpose: To investigate the patterns of regional gray matter (GM) and white matter (WM) atrophy, WM microstructural tissue damage, and changes in patients with a clinically isolated syndrome (CIS) suggestive of multiple sclerosis at 2 years from clinical onset. Materials and Methods: Institutional review board approval and written informed consent from all patients were obtained. Neurologic assessment and conventional, diffusion-tensor, and volumetric brain MR imaging sequences were performed in 37 patients with CIS within 2 months of clinical onset, and after 3, 12, and 24 months. Fourteen healthy control subjects also were studied. Longitudinal GM and WM volume changes and WM microstructural abnormalities were assessed by using voxel-based morphometry (P <.001, uncorrected) and tract-based spatial statistics (P <.05, corrected). Results: At 24 months, 33 of 37 (89%) patients had developed multiple sclerosis. At month 3, patients with CIS showed a transient volume increase in frontal, parietal, temporal, and cerebellar GM regions. At 12 months, patients with CIS developed atrophy of the thalami, caudate nuclei, cerebellum, and frontal, parietal, and temporal lobes. At 24 months GM volume of the frontal, temporal, and parietal cortical areas further decreased from that at 12 months. WM atrophy involved only a few WM regions at 2 months from clinical onset, with progressive involvement of additional WM tracts with time. A diffuse pattern of WM microstructural abnormalities was detected within 2 months of onset and had worsened at 24 months. Conclusion: After an acute inflammatory event, dynamic modifications of regional GM and WM damage occur in patients with CIS, with a progressive evolution of WM damage from disease onset and a transient, early increase in GM volume, followed by GM atrophy. Neurodegenerative processes start early in patients with multiple sclerosis. © RSNA, 2015.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Diagnosis of multiple sclerosis: A multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria
    (2018)
    Preziosa, Paolo (6506754661)
    ;
    Rocca, Maria A. (34973365100)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Meani, Alessandro (37018650000)
    ;
    Montalban, Xavier (7007177960)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Droby, Amgad (56507456100)
    ;
    Zipp, Frauke (55163047500)
    ;
    Calabrese, Massimiliano (14319094000)
    ;
    Sastre-Garriga, Jaume (6603920140)
    ;
    Dujmovic-Basuroski, Irena (6701590899)
    ;
    Rovira, Alex (7102462625)
    ;
    Filippi, Massimo (7202268530)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study
    (2022)
    Margoni, Monica (57194505671)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Meani, Alessandro (37018650000)
    ;
    Storelli, Loredana (57188565274)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Barkhof, Frederik (7102989379)
    ;
    Vrenken, Hugo (6506499076)
    ;
    Strijbis, Eva (14029391000)
    ;
    Gallo, Antonio (56421492900)
    ;
    Bisecco, Alvino (37090163000)
    ;
    Pareto, Deborah (6603301072)
    ;
    Sastre-Garriga, Jaume (6603920140)
    ;
    Ciccarelli, Olga (7003671038)
    ;
    Yiannakas, Marios (8833938100)
    ;
    Palace, Jacqueline (56351917800)
    ;
    Preziosa, Paolo (6506754661)
    ;
    Rocca, Maria A (34973365100)
    ;
    Filippi, Massimo (7202268530)
    ;
    De Stefano, N. (7006800085)
    ;
    Enzinger, C. (6602781849)
    ;
    Gasperini, C. (7005433129)
    ;
    Kappos, L. (7004559324)
    ;
    Palace, J. (57212483701)
    ;
    Rovira, À. (7102462625)
    ;
    Yousry, T. (7006486284)
    Objectives To evaluate white matter and grey matter T1-weighted (w)/T2w ratio (T1w/T2w ratio) in healthy controls and patients with multiple sclerosis, and its association with clinical disability. Methods In this cross-sectional study, 270 healthy controls and 434 patients with multiple sclerosis were retrospectively selected from 7 European sites. T1w/T2w ratio was obtained from brain T2w and T1w scans after intensity calibration using eyes and temporal muscle. Results In healthy controls, T1w/T2w ratio increased until 50-60 years both in white and grey matter. Compared with healthy controls, T1w/T2w ratio was significantly lower in white matter lesions of all multiple sclerosis phenotypes, and in normal-appearing white matter and cortex of patients with relapsing-remitting and secondary progressive multiple sclerosis (p≤0.026), but it was significantly higher in the striatum and pallidum of patients with relapsing-remitting, secondary progressive and primary progressive multiple sclerosis (p≤0.042). In relapse-onset multiple sclerosis, T1w/T2w ratio was significantly lower in white matter lesions and normal-appearing white matter already at Expanded Disability Status Scale (EDSS) <3.0 and in the cortex only for EDSS ≥3.0 (p≤0.023). Conversely, T1w/T2w ratio was significantly higher in the striatum and pallidum for EDSS ≥4.0 (p≤0.005). In primary progressive multiple sclerosis, striatum and pallidum showed significantly higher T1w/T2w ratio beyond EDSS=6.0 (p≤0.001). In multiple sclerosis, longer disease duration, higher EDSS, higher brain lesional volume and lower normalised brain volume were associated with lower lesional and cortical T1w/T2w ratio and a higher T1w/T2w ratio in the striatum and pallidum (β from-1.168 to 0.286, p≤0.040). Conclusions T1w/T2w ratio may represent a clinically relevant marker sensitive to demyelination, neurodegeneration and iron accumulation occurring at the different multiple sclerosis phases. ©
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: A voxelwise diffusion-tensor MR study
    (2011)
    Preziosa, Paolo (6506754661)
    ;
    Rocca, Maria A. (34973365100)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Stosic-Opincal, Tatjana (55886486600)
    ;
    Kacar, Katarina (12647164500)
    ;
    Absinta, Martina (18436249500)
    ;
    Caputo, Domenico (7103299939)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Comi, Giancarlo (7201788288)
    ;
    Filippi, Massimo (7202268530)
    Purpose: To apply voxelwise analysis of diffusion-tensor (DT) magnetic resonance (MR) tractography and T2-weighted MR lesion measurements to characterize intrinsic damage to the brain white matter (WM) tracts and the relation of this damage to the presence and location of focal lesions among the main clinical phenotypes of multiple sclerosis (MS). Materials and Methods: The study was conducted with institutional review board approval. Written informed consent was obtained from each participant. Brain dual-echo and DT MR images were obtained in 172 patients with MS (22 [13%] with clinically isolated syndromes [CIS] suggestive of MS, 51 [30%] with relapsing-remitting [RR] MS, 44 [26%] with secondary progressive MS, 20 [12%] with benign MS, 35 [20%] with primary progressive MS) and 46 healthy control subjects. Probability maps of the major brain WM tracts were produced. Between-group comparisons were assessed by using analysis of covariance. Results: Compared with the healthy control subjects, the patients with CIS had significantly increased (P<.001) mean diffusivity, axial diffusivity, and radial diffusivity in the majority of WM tracts. The primary progressive MS group showed diffuse increases in mean, axial, and radial diffusivity, with fractional anisotropy (FA) damage involving the majority of WM tracts. No relevant difference in diffusivity measures was found between the CIS and RR-MS groups. Compared with the benign MS group, the RR-MS group had reduced FA values in all WM tracts and decreased axial diffusivity in the majority of tracts. The secondary progressive MS group had pronounced damage to the majority of tracts and, compared with the benign MS group, pronounced FA alteration of the tracts relevant for motor impairment. Conclusion: Voxelwise assessment of DT MR index abnormalities is a rewarding strategy for understanding the heterogeneity of clinical MS phenotypes. © RSNA, 2011.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
    (2018)
    Filippi, Massimo (7202268530)
    ;
    Preziosa, Paolo (6506754661)
    ;
    Meani, Alessandro (37018650000)
    ;
    Ciccarelli, Olga (7003671038)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Rovira, Alex (7102462625)
    ;
    Frederiksen, Jette (7102315536)
    ;
    Enzinger, Christian (6602781849)
    ;
    Barkhof, Frederik (7102989379)
    ;
    Gasperini, Claudio (7005433129)
    ;
    Brownlee, Wallace (6701829357)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Montalban, Xavier (7007177960)
    ;
    Cramer, Stig P (55900737400)
    ;
    Pichler, Alexander (41262072600)
    ;
    Hagens, Marloes (57188881541)
    ;
    Ruggieri, Serena (57007863600)
    ;
    Martinelli, Vittorio (7005415704)
    ;
    Miszkiel, Katherine (6603758552)
    ;
    Tintorè, Mar (35416724300)
    ;
    Comi, Giancarlo (7201788288)
    ;
    Dekker, Iris (56001878600)
    ;
    Uitdehaag, Bernard (7006076844)
    ;
    Dujmovic-Basuroski, Irena (6701590899)
    ;
    Rocca, Maria A (34973365100)
    Background: In 2016, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network proposed modifications to the MRI criteria to define dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis in patients with clinically isolated syndrome (CIS). Changes to the DIS definition included removal of the distinction between symptomatic and asymptomatic lesions, increasing the number of lesions needed to define periventricular involvement to three, combining cortical and juxtacortical lesions, and inclusion of optic nerve evaluation. For DIT, removal of the distinction between symptomatic and asymptomatic lesions was suggested. We compared the performance of the 2010 McDonald and 2016 MAGNIMS criteria for multiple sclerosis diagnosis in a large multicentre cohort of patients with CIS to provide evidence to guide revisions of multiple sclerosis diagnostic criteria. Methods: Brain and spinal cord MRI and optic nerve assessments from patients with typical CIS suggestive of multiple sclerosis done less than 3 months from clinical onset in eight European multiple sclerosis centres were included in this retrospective study. Eligible patients were 16–60 years, and had a first CIS suggestive of CNS demyelination and typical of relapsing-remitting multiple sclerosis, a complete neurological examination, a baseline brain and spinal cord MRI scan obtained less than 3 months from clinical onset, and a follow-up brain scan obtained less than 12 months from CIS onset. We recorded occurrence of a second clinical attack (clinically definite multiple sclerosis) at months 36 and 60. We evaluated MRI criteria performance for DIS, DIT, and DIS plus DIT with a time-dependent receiver operating characteristic curve analysis. Findings: Between June 16, 1995, and Jan 27, 2017, 571 patients with CIS were screened, of whom 368 met all study inclusion criteria. At the last evaluation (median 50·0 months [IQR 27·0–78·4]), 189 (51%) of 368 patients developed clinically definite multiple sclerosis. At 36 months, the two DIS criteria showed high sensitivity (2010 McDonald 0·91 [95% CI 0·85–0·94] and 2016 MAGNIMS 0·93 [0·88–0·96]), similar specificity (0·33 [0·25–0·42] and 0·32 [0·24–0·41]), and similar area under the curve values (AUC; 0·62 [0·57–0·67] and 0·63 [0·58–0·67]). Performance was not affected by inclusion of symptomatic lesions (sensitivity 0·92 [0·87–0·96], specificity 0·31 [0·23–0·40], AUC 0·62 [0·57–0·66]) or cortical lesions (sensitivity 0·92 [0·87–0·95], specificity 0·32 [0·24–0·41], AUC 0·62 [0·57–0·67]). Requirement of three periventricular lesions resulted in slightly lower sensitivity (0·85 [0·78–0·90], slightly higher specificity (0·40 [0·32–0·50], and similar AUC (0·63 [0·57–0·68]). Inclusion of optic nerve evaluation resulted in similar sensitivity (0·92 [0·87–0·96]), and slightly lower specificity (0·26 [0·18–0·34]) and AUC (0·59 [0·55–0·64]). AUC values were also similar for DIT (2010 McDonald 0·61 [0·55–0·67] and 2016 MAGNIMS 0·61 [0·55–0·66]) and DIS plus DIT (0·62 [0·56–0·67] and 0·64 [0·58–0·69]). Interpretation: The 2016 MAGNIMS criteria showed similar accuracy to the 2010 McDonald criteria in predicting the development of clinically definite multiple sclerosis. Inclusion of symptomatic lesions is expected to simplify the clinical use of MRI criteria without reducing accuracy, and our findings suggest that needing three lesions to define periventricular involvement might slightly increase specificity, suggesting that these two factors could be considered during further revisions of multiple sclerosis diagnostic criteria. Funding: UK MS Society, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Dutch MS Research Foundation. © 2018 Elsevier Ltd
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study
    (2017)
    Preziosa, Paolo (6506754661)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Riccitelli, Gianna C. (57193017272)
    ;
    Dackovic, Jelena (19034069600)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Filippi, Massimo (7202268530)
    ;
    Rocca, Maria A. (34973365100)
    In this longitudinal study, we investigated the regional patterns of focal lesions accumulation, and gray (GM) and white matter (WM) atrophy progression over a five-year follow-up (FU) in multiple sclerosis (MS) patients and their association with clinical and cognitive deterioration. Neurological, neuropsychological and brain MRI (dual-echo and 3D T1-weighted sequences) assessments were prospectively performed at baseline (T0) and after a median FU of 4.9 years from 66 MS patients (including relapse-onset and primary progressive MS) and 16 matched controls. Lesion probability maps were obtained. Longitudinal changes of GM and WM volumes and their association with clinical and cognitive deterioration were assessed using tensor-based morphometry and SPM12. At FU, 36/66 (54.5%) MS patients showed a significant disability worsening, 14/66 (21.2%) evolved to a worse clinical phenotype, and 18/63 (28.6%) developed cognitive deterioration. At T0, compared to controls, MS patients showed a widespread pattern of GM atrophy, involving cortex, deep GM and cerebellum, and atrophy of the majority of WM tracts, which further progressed at FU (P < 0.001, uncorrected). Compared to stable patients, those with clinical and cognitive worsening showed a left-lateralized pattern of GM and WM atrophy, involving deep GM, fronto-temporo-parieto-occipital regions, cerebellum, and several WM tracts (P < 0.001, uncorrected).GM and WM atrophy of relevant brain regions occur in MS after 5 years. A different vulnerability of the two brain hemispheres to irreversible structural damage may be among the factors contributing to clinical and cognitive worsening in these patients. Hum Brain Mapp 38:5648–5665, 2017. © 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study
    (2017)
    Preziosa, Paolo (6506754661)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Riccitelli, Gianna C. (57193017272)
    ;
    Dackovic, Jelena (19034069600)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Filippi, Massimo (7202268530)
    ;
    Rocca, Maria A. (34973365100)
    In this longitudinal study, we investigated the regional patterns of focal lesions accumulation, and gray (GM) and white matter (WM) atrophy progression over a five-year follow-up (FU) in multiple sclerosis (MS) patients and their association with clinical and cognitive deterioration. Neurological, neuropsychological and brain MRI (dual-echo and 3D T1-weighted sequences) assessments were prospectively performed at baseline (T0) and after a median FU of 4.9 years from 66 MS patients (including relapse-onset and primary progressive MS) and 16 matched controls. Lesion probability maps were obtained. Longitudinal changes of GM and WM volumes and their association with clinical and cognitive deterioration were assessed using tensor-based morphometry and SPM12. At FU, 36/66 (54.5%) MS patients showed a significant disability worsening, 14/66 (21.2%) evolved to a worse clinical phenotype, and 18/63 (28.6%) developed cognitive deterioration. At T0, compared to controls, MS patients showed a widespread pattern of GM atrophy, involving cortex, deep GM and cerebellum, and atrophy of the majority of WM tracts, which further progressed at FU (P < 0.001, uncorrected). Compared to stable patients, those with clinical and cognitive worsening showed a left-lateralized pattern of GM and WM atrophy, involving deep GM, fronto-temporo-parieto-occipital regions, cerebellum, and several WM tracts (P < 0.001, uncorrected).GM and WM atrophy of relevant brain regions occur in MS after 5 years. A different vulnerability of the two brain hemispheres to irreversible structural damage may be among the factors contributing to clinical and cognitive worsening in these patients. Hum Brain Mapp 38:5648–5665, 2017. © 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Relationship between damage to the cerebellar peduncles and clinical disability in multiple sclerosis
    (2014)
    Preziosa, Paolo (6506754661)
    ;
    Rocca, Maria A. (34973365100)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Stosic-Opincal, Tatjana (55886486600)
    ;
    Dackovic, Jelena (19034069600)
    ;
    Copetti, Massimiliano (24474249000)
    ;
    Caputo, Domenico (7103299939)
    ;
    Filippi, Massimo (7202268530)
    Purpose: To assess whether a structural disconnection between the cerebellum and the cerebral hemispheres contributes to cerebellar and brainstem symptoms in multiple sclerosis (MS). Materials and Methods: This study was approved by the local ethics committee, and written informed consent was obtained from each participant. Brain T2 lesion load, cerebellar white matter and gray matter volumes, and tract-specific measures of the middle and superior cerebellar peduncles were derived from 172 patients with MS and 46 control subjects. Predictors of clinical impairment, which was determined at ambulation and with cerebellar and brainstem functional system scores, were identified by using random forest analysis. Results: Of the 172 patients, 112 (65%) had middle cerebellar peduncle T2 lesions and 74 (43%) had superior cerebellar peduncle T2 lesions. T2 lesions in the middle and superior cerebellar peduncles were more common in clinically impaired patients than in unimpaired patients (P =.05 to <.0001). Most conventional magnetic resonance imaging metrics were more abnormal in impaired patients than in unimpaired patients (P =.03 to <.0001). Except for axial diffusivity, diffusivity abnormalities of the middle and superior cerebellar peduncles were more severe in clinically impaired patients than in unimpaired patients (P =.04 to <.0001). A minimal overlap was found between diffusivity abnormalities and T2 lesions. Compared with volumetric measures of T2 lesions or cerebellar atrophy, diffusivity measures of middle or superior cerebellar peduncle damage enabled better differentiation between clinically impaired and unimpaired patients (C statistics: 61%-70%). Conclusion: The assessment of middle and superior cerebellar peduncle damage contributes to the explanation of cerebellar and/or brainstem symptoms and ambulatory impairment in MS. © 2014 RSNA.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD
    (2025)
    Cacciaguerra, Laura (57185733400)
    ;
    Storelli, Loredana (57188565274)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Preziosa, Paolo (6506754661)
    ;
    Mesaros, Sharlota (7004307592)
    ;
    Martinelli, Vittorio (55390760700)
    ;
    Moiola, Lucia (57190092602)
    ;
    Radaelli, Marta (25947736800)
    ;
    Ivanovic, Jovana (57196371316)
    ;
    Tamas, Olivera (57202112475)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Filippi, Massimo (58068386500)
    ;
    Rocca, Maria A (34973365100)
    Background: The understanding of disease pathophysiology is pivotal for tailored treatments. The spatial distribution of brain damage relies on the regional antigen expression and the local balance of susceptibility and protective elements. Objective: As proof-of-concept, we investigated the spatial association between brain damage and gene expression in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD). Methods: In this multicenter cross-sectional study, 90 AQP4 + NMOSD patients and 94 age-matched healthy controls underwent a brain magnetic resonance imaging (MRI). We used T2-hyperintense lesion probability maps and white/gray matter atrophy as proxies of inflammation and neurodegeneration. The association with the expression of 266 candidate genes was obtained with the Multimodal Environment for Neuroimaging and Genomic Analysis platform. A functional-enrichment analysis investigated overrepresented biological processes. Results: In AQP4 + NMOSD, T2-hyperintense lesions were mainly periventricular; atrophy mostly involved the visual pathway. The expression of AQP4 and complement (C4a and C5) was associated with both inflammation and neurodegeneration. Complement activation and regulation/uptake of the insulin-like growth factor were the most relevant enriched pathways. Nonspecific pathways related to DNA synthesis and repair were associated with brain atrophy. Conclusions: Quantitative MRI and gene expression atlas identified the key elements of AQP4 + NMOSD pathophysiology. This analysis could help in understanding the pathophysiology of antibody-mediated autoimmune disorders. © The Author(s), 2024.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD
    (2025)
    Cacciaguerra, Laura (57185733400)
    ;
    Storelli, Loredana (57188565274)
    ;
    Pagani, Elisabetta (7005421345)
    ;
    Preziosa, Paolo (6506754661)
    ;
    Mesaros, Sharlota (7004307592)
    ;
    Martinelli, Vittorio (55390760700)
    ;
    Moiola, Lucia (57190092602)
    ;
    Radaelli, Marta (25947736800)
    ;
    Ivanovic, Jovana (57196371316)
    ;
    Tamas, Olivera (57202112475)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Filippi, Massimo (58068386500)
    ;
    Rocca, Maria A (34973365100)
    Background: The understanding of disease pathophysiology is pivotal for tailored treatments. The spatial distribution of brain damage relies on the regional antigen expression and the local balance of susceptibility and protective elements. Objective: As proof-of-concept, we investigated the spatial association between brain damage and gene expression in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD). Methods: In this multicenter cross-sectional study, 90 AQP4 + NMOSD patients and 94 age-matched healthy controls underwent a brain magnetic resonance imaging (MRI). We used T2-hyperintense lesion probability maps and white/gray matter atrophy as proxies of inflammation and neurodegeneration. The association with the expression of 266 candidate genes was obtained with the Multimodal Environment for Neuroimaging and Genomic Analysis platform. A functional-enrichment analysis investigated overrepresented biological processes. Results: In AQP4 + NMOSD, T2-hyperintense lesions were mainly periventricular; atrophy mostly involved the visual pathway. The expression of AQP4 and complement (C4a and C5) was associated with both inflammation and neurodegeneration. Complement activation and regulation/uptake of the insulin-like growth factor were the most relevant enriched pathways. Nonspecific pathways related to DNA synthesis and repair were associated with brain atrophy. Conclusions: Quantitative MRI and gene expression atlas identified the key elements of AQP4 + NMOSD pathophysiology. This analysis could help in understanding the pathophysiology of antibody-mediated autoimmune disorders. © The Author(s), 2024.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback